Molly E. Steed

1.2k total citations
29 papers, 959 citations indexed

About

Molly E. Steed is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Molly E. Steed has authored 29 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 15 papers in Pharmacology and 12 papers in Clinical Biochemistry. Recurrent topics in Molly E. Steed's work include Antimicrobial Resistance in Staphylococcus (22 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Molly E. Steed is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (22 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Molly E. Steed collaborates with scholars based in United States, Colombia and United Kingdom. Molly E. Steed's co-authors include Michael J. Rybak, Nicholas Britt, Emily Potter, Nimish Patel, Céline Vidaillac, Brian J. Werth, Glenn W. Kaatz, César A. Arias, Barbara E. Murray and J. Tyrone Gibson and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Molly E. Steed

29 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Molly E. Steed United States	18	650	363	341	315	284	29	959
Abdalhamid M Lagnf United States	18	468 0.7×	343 0.9×	317 0.9×	307 1.0×	366 1.3×	43	937
Matthew G. Stilwell United States	15	457 0.7×	327 0.9×	270 0.8×	334 1.1×	401 1.4×	20	1.0k
Kevin W. Ward United States	13	424 0.7×	315 0.9×	195 0.6×	258 0.8×	380 1.3×	26	885
Patricia A. Hogan United States	17	826 1.3×	525 1.4×	312 0.9×	185 0.6×	309 1.1×	24	1.2k
Jordan R. Smith United States	17	546 0.8×	275 0.8×	220 0.6×	216 0.7×	207 0.7×	27	781
Tsigereda Tekle United States	15	418 0.6×	418 1.2×	256 0.8×	317 1.0×	693 2.4×	28	1.2k
Anthony M. Casapao United States	15	728 1.1×	435 1.2×	293 0.9×	283 0.9×	115 0.4×	29	879
A. Evans United States	13	576 0.9×	437 1.2×	223 0.7×	191 0.6×	185 0.7×	15	882
Carmen Betriú Spain	20	451 0.7×	331 0.9×	406 1.2×	259 0.8×	323 1.1×	55	1.1k
Michael A. Pfaller United States	18	471 0.7×	316 0.9×	389 1.1×	211 0.7×	299 1.1×	27	1.0k

Countries citing papers authored by Molly E. Steed

Since Specialization

Citations

This map shows the geographic impact of Molly E. Steed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly E. Steed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly E. Steed more than expected).

Fields of papers citing papers by Molly E. Steed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly E. Steed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly E. Steed. The network helps show where Molly E. Steed may publish in the future.

Co-authorship network of co-authors of Molly E. Steed

This figure shows the co-authorship network connecting the top 25 collaborators of Molly E. Steed. A scholar is included among the top collaborators of Molly E. Steed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly E. Steed. Molly E. Steed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodge, Jacob, et al.. (2021). Novel insights into negative pressure wound healing from an in situ porcine perspective. Wound Repair and Regeneration. 30(1). 64–81. 4 indexed citations

Jorgensen, Sarah C J, Trang D Trinh, Evan J Zasowski, et al.. (2020). Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime–Avibactam. Infectious Diseases and Therapy. 9(2). 291–304. 15 indexed citations

Britt, Nicholas, et al.. (2020). Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum. International Journal of Antimicrobial Agents. 55(4). 105898–105898. 5 indexed citations

Jorgensen, Sarah C J, Trang D Trinh, Evan J Zasowski, et al.. (2019). Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections. Open Forum Infectious Diseases. 6(12). ofz522–ofz522. 101 indexed citations

Britt, Nicholas, Emily Potter, Nimish Patel, & Molly E. Steed. (2017). Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrobial Agents and Chemotherapy. 61(5). 20 indexed citations

Britt, Nicholas, Emily Potter, Nimish Patel, & Molly E. Steed. (2016). Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clinical Infectious Diseases. 64(5). 605–613. 71 indexed citations

Britt, Nicholas, et al.. (2016). Relationship between vancomycin tolerance and clinical outcomes inStaphylococcus aureusbacteraemia. Journal of Antimicrobial Chemotherapy. 72(2). 535–542. 16 indexed citations

Britt, Nicholas, Nimish Patel, Rebecca T. Horvat, & Molly E. Steed. (2016). Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy. 60(5). 3070–3075. 15 indexed citations

Britt, Nicholas, Emily Potter, Nimish Patel, & Molly E. Steed. (2015). Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clinical Infectious Diseases. 61(6). 871–878. 97 indexed citations

10.

Britt, Nicholas, et al.. (2014). Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection. Infectious Diseases and Therapy. 3(2). 321–331. 35 indexed citations

11.

Steed, Molly E., et al.. (2013). Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity. Infectious Diseases and Therapy. 2(2). 187–200. 7 indexed citations

12.

Casapao, Anthony M., Molly E. Steed, Donald P. Levine, & Michael J. Rybak. (2012). Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection. Expert Opinion on Pharmacotherapy. 13(8). 1177–1186. 14 indexed citations

13.

Steed, Molly E., et al.. (2012). Evaluation of Ceftaroline Activity versus Ceftriaxone against Clinical Isolates of Streptococcus pneumoniae with Various Susceptibilities to Cephalosporins in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 56(5). 2691–2695. 10 indexed citations

14.

Levy, Dana, Molly E. Steed, Michael J. Rybak, et al.. (2012). Successful treatment of a left ventricular assist device infection with daptomycin non‐susceptible methicillin‐resistant Staphylococcus aureus: case report and review of the literature. Transplant Infectious Disease. 14(5). E89–96. 16 indexed citations

15.

Steed, Molly E., et al.. (2012). Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations. Antimicrobial Agents and Chemotherapy. 56(6). 3174–3180. 82 indexed citations

16.

Patel, Diixa, Céline Vidaillac, Molly E. Steed, et al.. (2011). Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. International Journal of Antimicrobial Agents. 38(5). 442–446. 36 indexed citations

17.

Vidaillac, Céline, Molly E. Steed, & Michael J. Rybak. (2011). Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Model. Antimicrobial Agents and Chemotherapy. 55(5). 2160–2165. 8 indexed citations

18.

Steed, Molly E., Céline Vidaillac, & Michael J. Rybak. (2010). Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations. Antimicrobial Agents and Chemotherapy. 54(12). 5187–5192. 47 indexed citations

19.

Steed, Molly E. & Michael J. Rybak. (2010). Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram‐Positive Pathogens. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(4). 375–389. 70 indexed citations

20.

Armstrong, Frederick H., Harry Campbell, Cory C. Cleveland, et al.. (1997). Liquid Chromatographic Determination of Tilmicosin in Swine Feed at 200–400 mg/kg Level: Interlaboratory Study. Journal of AOAC International. 80(6). 1156–1160. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact